Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-12

Clinical Trial Update: UCB Therapy in Acquired Brain Injury [Phase 1]

View source ↗

Summary

Phase 1 trial of UCB Therapy for acquired brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UCB Therapy

Snippet

Sponsor: MinYoung Kim, M.D. | Conditions: Acquired Brain Injury | Phase 1 | Status: COMPLETED